Safety and Efficacy of Treatment with Once-Daily Ledipasvir/Sofosbuvir (90/400 mg) for 12 Weeks in Genotype 1 HCV-Infected Patients with Severe Renal ImpairmentEric Lawitz,Charles S. Landis,Benedict J. Maliakkal,Maurizio Bonacini,Grisell Ortiz-Lasanta,Jie Zhang,Erik Mogalian,Shampa De-Oertel,Anu O. Osinusi,Diana M. Brainard,John G. McHutchison,Steven L. Flamm,Stuart C. Gordon,Edward J. GaneHEPATOLOGY（2017）引用 25|浏览34暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
